Neonatal Losartan Treatment Suppresses Renal Expression of Molecules Involved in Cell-Cell and Cell-Matrix Interactions

Journal of the American Society of Nephrology

Volumn 15, Issue 5, 2004, Pages 1232-1243

  Chen, Yun ^a   Lasaitiene, Daina ^a   Gabrielsson, Britt G ^b   Carlsson, Lena ^b   Billig, Håkan ^a   Carlsson, Björn ^b   Marcussen, Niels ^c   Sun, Xiao Feng ^d   Friberg, Peter ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA INTEGRIN; ANGIOTENSIN 2 RECEPTOR; LIPOXYGENASE; LOSARTAN; MAJOR HISTOCOMPATIBILITY ANTIGEN; SYNDECAN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE IDENTIFICATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 1942474529     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000123690.75029.3F     Document Type: Article

References (36)

1. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23: 171-175, 1994
2. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R: Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49: 460-467, 2001
3. Nigam SK, Aperia AC, Brenner BM: Development and maturation of the kidney. In: The Kidney, edited by Brenner BM, Rector FC, Philadelphia, WB Saunders Company, 1996, pp 72-98
4. Guron G, Friberg P: An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18: 123-137, 2000
5. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA: Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485-492, 1994
6. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA: Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269: F110-F115, 1995
7. Gomez RA, Norwood VF, Tufro-McReddie A: Development of the kidney vasculature. Microsc Res Tech 39: 254-260, 1997
8. Tufro-McReddie A, Harrison JK, Everett AD, Gomez RA: Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J Clin Invest 91: 530-537, 1993
9. Falk M, Salmivirta K, Durbeej M, Larsson E, Ekblom M, Vestweber D, Ekblom P: Integrin alpha 6B beta 1 is involved in kidney tubulogenesis in vitro. J Cell Sci 109[Suppl]: 2801-2810, 1996
10. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122: 3537-3547, 1996
11. Woods A: Syndecans: Transmembrane modulators of adhesion and matrix assembly. J Clin Invest 107: 935-941, 2001
12. Sundelin B, Bohman SO: Postnatal development of the interstitial tissue of the rat kidney. Anat Embryol (Berl) 182: 307-317, 1990
13. Carey AV, Carey RM, Gomez RA: Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 19: 11168-11175, 1992
14. Kim JA, Gu JL, Natarajan R, Berliner JA, Nadler JL: A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II. Arterioscler Thromb Vasc Biol 15: 942-948, 1995
15. Saito F, Hori MT, Ideguchi Y, Berger M, Golub M, Stern N, Tuck ML: 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension 20: 138-143, 1992
16. Nakao J, Ooyama T, Ito H, Chang WC, Murota S: Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration. Atherosclerosis 44: 339-342, 1982
17. Reddy MA, Thimmalapura PR, Lanting L, Nadler JL, Fatima S, Natarajan R: The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J Biol Chem 277: 9920-9928, 2002
18. McCausland JE, Ryan GB, Alcorn D: Angiotensin converting enzyme inhibition in the postnatal rat results in decreased cell proliferation in the renal outer medulla. Clin Exp Pharmacol Physiol 23: 552-554, 1996
19. Nagata M, Tanimoto K, Fukamizu A, Kon Y, Sugiyama F, Yagami K, Murakami K, Watanabe T: Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest 75: 745-753, 1996
20. Lasaitiene D, Chen Y, Guron G, Marcussen N, Tarkowski A, Telemo E, Friberg P: Perturbed medullary tubulogenesis in neonatal rat exposed to renin-angiotensin system inhibition. Nephrol Dial Transplant 18: 2534-2541, 2003
21. Zhu C, Wang X, Hagberg H, Blomgren K: Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J Neurochem 75: 819-829, 2000
22. Kriz W, Bankir L: A standard nomenclature for structures of the kidney. The Renal Commission of the International Union of Physiological Sciences (IUPS). Kidney Int 33: 1-7, 1988
23. Murphy-Ullrich JE: The de-adhesive activity of matricellular proteins: Is intermediate cell adhesion an adaptive state? J Clin Invest 107: 785-790, 2001
24. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE: Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol 151: 779-788, 2000
25. Giampuzzi M, Botti G, Di Duca M, Arata L, Ghiggeri G, Gusmano R, Ravazzolo R, Di Donato A: Lysyl oxidase activates the transcription activity of human collagene III promoter, Possible involvement of Ku antigen. J Biol Chem 275: 36341-36349, 2000
26. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000
27. Maric C, Aldred GP, Antoine AM, Dean RG, Eitle E, Mendelsohn FA, Williams DA, Harris PJ, Alcorn D: Effects of angiotensin II on cultured rat renomedullary interstitial cells are mediated by AT1A receptors. Am J Physiol 271: F1020-F1028, 1996
28. Klass CM, Couchman JR, Woods A: Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci 113[Suppl]:493-506, 2000.
29. Gailit J, Colflesh D, Rabiner I, Simone J, Goligorsky MS: Redistribution and dysfunction of integrins in cultured renal epithelial cells exposed to oxidative stress. Am J Physiol 264: F149-F157, 1993
30. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H: Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 119: 841-854, 1993
31. Guron G, Nilsson A, DiBona GF, Sundelin B, Nitescu N, Friberg P: Renal adaptation to dietary sodium restriction and loading in rats treated neonatally with enalapril. Am J Physiol 273: R1421-R1429, 1997
32. Barclay AN: Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens. Immunology 44: 727-736, 1981
33. Marx C, Bornstein SR, Wolkersdorfer GW, Peter M, Sippell WG, Scherbaum WA: Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. J Clin Endocrinol Metab 82: 3136-3140, 1997
34. Natarajan R, Gonzales N, Lanting L, Nadler J: Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension 23: I142-I147, 1994
35. Nie D, Tang K, Diglio C, Honn KV: Eicosanoid regulation of angiogenesis: Role of endothelial arachidonate 12-lipoxygenase. Blood 95: 2304-2311, 2000
36. Guron G, Adams MA, Sundelin B, Friberg P: Neonatal angiotensin-converting enzyme inhibition in the rat induces persistent abnormalities in renal function and histology. Hypertension 29: 91-97, 1997